Fig. 1From: Differential efficacy of cisplatin plus pemetrexed between L858R and Del-19 in advanced EGFR-mutant non-squamous non-small cell lung cancerKaplan-Meier curves for a progression-free survival and b overall survival among patients in L858R group, Del-19 group, and wild type groupBack to article page